Xodo Andrea, Pilon Fabio, Gregio Alessandro, Ongaro Giulia, Desole Alessandro, Barbui Federico, Romagnoni Giovanni, Milite Domenico
Division of Vascular and Endovascular Surgery, "San Bortolo" Hospital-AULSS8 Berica, 36100 Vicenza, Italy.
J Clin Med. 2025 Apr 15;14(8):2709. doi: 10.3390/jcm14082709.
The aim of this case series is to describe technical considerations and preliminary outcomes of preventive aneurysm sac embolization during fenestrated or branched EVAR (embo F/BEVAR technique). Five male patients suffering from juxtarenal or pararenal abdominal aortic aneurysms, preoperatively identified as being at "high risk" of type 2 endoleak (EL2) development, were treated with embo F/BEVAR. The patients presented at least two of these risk factors: patent inferior mesenteric artery (IMA) > 3 mm; more than three pairs of patent lumbar arteries (LAAs); more than two pairs of LAAs, associated with an accessory efferent artery or at least a pair of intercostal arteries; aneurysm thrombus volume < 40%; aneurysm sac diameter > 65 mm. Embo F/BEVAR was performed with 15 × 20 mm MReye Inconel coils (Cook Medical, Limerick, Ireland), using different aortic endografts. Technical success was 100%, with no complications related to perioperative or postoperative coils implantation. An average number of 11 ± 4.4 coils/patient was deployed. No reinterventions were observed during the follow-up (12.4 ± 3.6 months). One case of EL2 (20%) was detected during the follow-up, without aneurysm sac enlargement. According to this preliminary experience, embo F/BEVAR technique with Inconel coils seems a feasible adjunctive procedure to manage the risk of EL2 after FEVAR or BEVAR, allowing a simple follow-up with low levels of scatter artifacts, and ensuring limited additional procedural costs. Moreover, embo F/BEVAR can be used with different endografts, requiring minimal increases in operating times. Further studies with larger cohorts of patients and longer follow-up periods are mandatory to better define the potential of this technique and its limitations.
本病例系列的目的是描述开窗或分支型腹主动脉瘤腔内修复术(embo F/BEVAR技术)期间预防性动脉瘤囊栓塞的技术要点和初步结果。5例患有近肾或肾旁腹主动脉瘤的男性患者,术前被确定为发生2型内漏(EL2)的“高风险”患者,接受了embo F/BEVAR治疗。这些患者至少存在以下两个风险因素:肠系膜下动脉(IMA)通畅且直径>3mm;三对以上腰动脉(LAA)通畅;两对以上LAA,伴有副传出动脉或至少一对肋间动脉;动脉瘤血栓体积<40%;动脉瘤囊直径>65mm。使用不同的主动脉腔内移植物,采用15×20mm MReye铱铬合金弹簧圈(库克医疗公司,爱尔兰利默里克)进行embo F/BEVAR。技术成功率为100%,未发生与围手术期或术后弹簧圈植入相关的并发症。每位患者平均植入11±4.4个弹簧圈。随访期间(12.4±3.6个月)未观察到再次干预。随访期间发现1例EL2(20%),动脉瘤囊未增大。根据这一初步经验,使用铱铬合金弹簧圈的embo F/BEVAR技术似乎是一种可行的辅助方法,可用于管理FEVAR或BEVAR术后的EL2风险,随访简单,散射伪影水平低,并确保额外的手术成本有限。此外,embo F/BEVAR可与不同的腔内移植物联合使用,手术时间增加极少。必须进行更大规模患者队列和更长随访期的进一步研究,以更好地确定该技术的潜力及其局限性。